Journal article
Cost effectiveness analysis of escitalopram compared to venlafaxine and fluvoxamine in treatment of major depressive disorder
Abstract
Objective. To compare the costs and effectiveness of escitalopram with venlafaxine and fluvoxamine for treatment of major depressive disorder (MDD) from the societal perspective in Singapore. Methods. The decision analytical model consisted of two pathways, one for primary care and the other for secondary care over a time horizon of 6 months. The parameters in the model were derived from clinical trials and results of a survey on local general …
Authors
Xie F; Despiegel N; Danchenko N; Hansen K
Journal
International Journal of Psychiatry in Clinical Practice, Vol. 13, No. 1, pp. 59–69
Publisher
Taylor & Francis
Publication Date
January 2009
DOI
10.1080/13651500802450506
ISSN
1365-1501